Lifetime Probability of Developing Atrial Fibrillation

Atrial fibrillation (AFib) is the most common cardiac arrhythmia, affecting about 6-12 million Americans currently and projected to affect 16 million by 2050. The lifetime risk of developing AFib is approximately 25% (1 in 4) for adults over 40. Prevalence increases dramatically with age: about 1% of people in their 40s-50s, 5% in their 60s, 10% in their 70s, and 15-20% of those over 80.

AFib causes the heart's upper chambers to beat irregularly and often rapidly. This irregular rhythm increases the risk of blood clots forming in the heart, which can travel to the brain and cause a stroke. People with AFib have a 5-fold increased risk of stroke. AFib is also associated with heart failure, cognitive decline, and reduced quality of life.

Treatment focuses on rate control (slowing the heart rate), rhythm control (restoring normal rhythm through medications or catheter ablation), and stroke prevention (with blood thinners). Direct oral anticoagulants (DOACs) have largely replaced warfarin for stroke prevention due to better safety profiles. Catheter ablation has improved significantly and is now recommended earlier in the disease course. Smartwatch-based AFib detection (Apple Watch, Samsung Galaxy, Fitbit) has raised awareness but also led to discussions about overdiagnosis in younger, low-risk populations.